Experience

Davis Polk advised the representatives of the underwriters in connection with the $122.4 million public offering of 4,800,000 shares of common stock by Flexion Therapeutics, Inc. The…

Davis Polk advised Rumo S.A. in connection with the offering by Rumo of 220,000,000 common shares for an aggregate amount of R$2.6 billion (approximately $780 million). The common shares…

Davis Polk advised the book-running manager on an SEC-registered offering by Mohawk Capital Finance S.A. of floating-rate notes due 2019. The notes are fully and unconditionally…

Davis Polk advised DXC Technology Company on its SEC-registered offering of $650 million aggregate principal amount of senior floating-rate notes due 2021.  DXC is an end-to-end IT…

Davis Polk advised DXC Technology Company in connection with its registered exchange offers of (i) up to $445.265 million aggregate principal amount of DXC’s new 4.45% senior notes due 2022…

Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by Flexion Therapeutics, Inc. of $201.25 million aggregate principal amount of its 3.375% convertible…

Davis Polk advised the underwriter in connection with an SEC-registered secondary offering of 1,800,000 shares of Veritiv Corporation’s common stock by UWW Holdings, LLC at a price to the…

Davis Polk advised Rumo Luxembourg S.à r.l., as issuer, and Rumo S.A., as guarantor, in connection with Rumo Luxembourg’s $750 million offering of 7.375% senior notes due 2024, which were…